The University of Chicago Header Logo

Connection

Mark Talamonti to Survival Rate

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Survival Rate.
Mark Talamonti
Connection Strength
0.564
Survival Rate
  1. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009 Jan; 249(1):63-71.
    View in: PubMed
    Score: 0.054
  2. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007 Aug; 246(2):173-80.
    View in: PubMed
    Score: 0.049
  3. A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol. 2006 Feb; 13(2):150-8.
    View in: PubMed
    Score: 0.044
  4. Multimodal Therapy May be Key to Improving Survival for Octogenarians Undergoing Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: An American Multicenter Analysis. Ann Surg Oncol. 2025 May; 32(5):3582-3592.
    View in: PubMed
    Score: 0.041
  5. Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function. Surgery. 2018 03; 163(3):582-586.
    View in: PubMed
    Score: 0.025
  6. Laparoscopic Distal Pancreatectomy for Cancer Provides Oncologic Outcomes and Overall Survival Identical to Open Distal Pancreatectomy. J Gastrointest Surg. 2017 Oct; 21(10):1620-1625.
    View in: PubMed
    Score: 0.025
  7. Time to Initiation of Adjuvant Chemotherapy in Pancreas Cancer: A Multi-Institutional Experience. Ann Surg Oncol. 2017 Sep; 24(9):2770-2776.
    View in: PubMed
    Score: 0.024
  8. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma. Surgery. 2016 12; 160(6):1466-1476.
    View in: PubMed
    Score: 0.023
  9. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surg. 2016 08 17; 151(8):e161137.
    View in: PubMed
    Score: 0.023
  10. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head. Surgery. 2016 09; 160(3):714-24.
    View in: PubMed
    Score: 0.023
  11. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy. Ann Surg Oncol. 2016 06; 23(6):1956-62.
    View in: PubMed
    Score: 0.022
  12. Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base. J Am Coll Surg. 2015 Jul; 221(1):175-84.
    View in: PubMed
    Score: 0.021
  13. The laparoscopic approach to distal pancreatectomy for ductal adenocarcinoma results in shorter lengths of stay without compromising oncologic outcomes. Am J Surg. 2015 Mar; 209(3):557-63.
    View in: PubMed
    Score: 0.021
  14. Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2015 Jul; 22(7):2209-17.
    View in: PubMed
    Score: 0.020
  15. Surgical resection provides an overall survival benefit for patients with small pancreatic neuroendocrine tumors. J Gastrointest Surg. 2015 Jan; 19(1):117-23; discussion 123.
    View in: PubMed
    Score: 0.020
  16. Gastrointestinal lymphoma. A case for primary surgical resection. Arch Surg. 1990 Aug; 125(8):972-6; discussion 976-7.
    View in: PubMed
    Score: 0.015
  17. Risk-based selective referral for cancer surgery: a potential strategy to improve perioperative outcomes. Ann Surg. 2010 Apr; 251(4):708-16.
    View in: PubMed
    Score: 0.015
  18. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg. 2008 Dec; 12(12):2078-86.
    View in: PubMed
    Score: 0.013
  19. Squamous cell carcinoma of the anal canal: utilization and outcomes of recommended treatment in the United States. Ann Surg Oncol. 2008 Jul; 15(7):1948-58.
    View in: PubMed
    Score: 0.013
  20. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg. 2008 Mar; 247(3):490-500.
    View in: PubMed
    Score: 0.013
  21. Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum. 2008 Feb; 51(2):154-61.
    View in: PubMed
    Score: 0.013
  22. Adequacy and importance of lymph node evaluation for colon cancer in the elderly. J Am Coll Surg. 2008 Feb; 206(2):247-54.
    View in: PubMed
    Score: 0.013
  23. Impact of adjuvant radiation on survival: a note of caution when using cancer registry data to evaluate adjuvant treatments. Ann Surg Oncol. 2007 Dec; 14(12):3321-7.
    View in: PubMed
    Score: 0.012
  24. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007 Sep; 246(3):375-81; discussion 381-4.
    View in: PubMed
    Score: 0.012
  25. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery. 2001 Oct; 130(4):677-82; discussion 682-5.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.